Abstract
As the experience of stigma and its psychological dimensions require careful measurement, the purpose of this study was to examine the psychometric properties and factor structure of the Feelings of Stigmatization Questionnaire (FSQ). A total of 170 participants with psoriasis and 124 with atopic dermatitis (AD) completed the FSQ. AD participants self-rated AD severity, while psoriasis severity was determined by a clinician. Confirmatory (CFA) and exploratory factor analytic (EFA) techniques were used to examine the factor structure of the FSQ. The FSQ total score was not related to age, age at onset, illness duration or psoriasis severity but it was negatively associated with AD severity (r = −.25, p < .01). The original six-factor structure of the FSQ was not replicated in our sample. Using EFA, a fixed three-factor solution proved the most stable, with the dimensions of feeling flawed, anticipation of rejection and secrecy, and positive attitudes towards skin disease being identified.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Barrowclough, C., Tarrier, N., Humphreys, L., Ward, J., Gregg, L., & Andrews, B. (2003). Self-esteem in schizophrenia: Relationships between self-evaluation, family attitudes, and symptomatology. Journal of Abnormal Psychology, 112, 92–99.
Bentler, P. M. (1990). Comparative fit indexes in structural models. Psychological Bulletin, 107, 238–246.
Calhoun, L., & Tedeshi, R. (1999). Facilitating posttraumatic growth: A clinician’s guide. Mahwah, NJ: Lawrence Erlbaum Associates.
Catell, R. B. (1965). Factor analysis and introduction to essentials: The purpose and underlying models. Biometrics, 21, 190–215.
Corrigan, P. W. (2000). Mental health stigma as social attribution: Implications for research methods and attitude change. Clinical Psychology Science Practice 7, 48–67.
Fan, X., Thompson, B., & Wang, L. (1999). The effects of sample size, estimation methods, and model specification on SEM fit indices. Structural Equation Modeling, 6, 56–83.
Feldman, S. R., Fleischer, A. B., Reboussin, D. M., Rapp, S. R., Exum, M. L., Clark, A. R., et al. (1996). The self-administered psoriasis area and severity index is valid and reliable. Journal of Investigative Dermatology, 106, 183–186.
Feldman, S. R., Fleischer, A. B., & Rapp, S. R. (1997). The self-administered psoriasis area and severity index. Retinoids, 13, 64–65.
Field, A. (2005). Discovering statistics using SPSS, (2nd ed.). London: Sage Publications Limited.
Fleischer, A. B., Rapp, S. R., Reboussin, D., Vanarthos, J. C., & Feldman, S. R. (1994). Patient measure of psoriasis severity with a structured assessment. Journal of Investigative Dermatology, 102, 967–969.
Fortune, D. G., Main, C. J., O’Sullivan, T. M., & Griffiths, C. E. M. (1997). Quality of life in patients with psoriasis: The contribution of clinical variables and psoriasis specific stress. British Journal of Dermatology, 137, 755–760.
Fortune, D. G., Richards, H. L., Main, C. J., & Griffiths, C. E. M. (1998). What patients with psoriasis believe about their condition. Journal of the American Academy of Dermatology, 39, 196–201.
Fortune, D. G., Richards, H. L., Main, C. J., Kirby, B., Bowcock, S., & Griffiths, C. E. M. (2002). A cognitive-behavioural symptom management programme as an adjunct in psoriasis therapy. British Journal of Dermatology, 146, 458–465.
Fortune, D. G., Richards, H. L., Main, C. J., & Griffiths, C. E. M. (2004). Targeting cognitive-behavioural therapy to patients’ implicit models of psoriasis: Results from a patient preference controlled trial. British Journal of Clinical Psychology, 43, 65–82.
Fortune, D. G., Richards, H. L., Griffiths, C. E. M., & Main, C. J. (2005). Adversarial growth in patients undergoing treatment for psoriasis: A prospective study of the ability of patients to construe benefits from negative events. Psychology Health and Medicine, 10, 44–56.
Fredriksson, T., & Pettersson, U. (1978). Severe psoriasis: Oral therapy with a new retinoid. Dermatologica, 157, 238–244.
Ginsburg, I. H., & Link, B. G. (1989). Feelings of stigmatization in patients with psoriasis. Journal of the American Academy of Dermatology, 20, 53–63.
Ginsburg, I. H., & Link, B. G. (1993). Psychosocial consequences of rejection and stigma feelings in psoriasis patients. International Journal of Dermatology, 32, 587–591.
Goffman, E. (1963). Stigma: Notes on the management of spoiled identity. Englewood Cliffs, NJ: Prentice-Hall.
Hu, L., & Bentler, P. M. (1999). Cutoff criteria for fit indexes in covariance structure analysis: Conventional criteria versus new alternatives. Structural Equation Modeling, 6, 1–55.
Jacoby, A. (1994). Felt versus enacted stigma: A concept revisited. Evidence from a study of people with epilepsy in remission. Society Science Medicine, 34, 269–274.
Jowett, S., & Ryan, T. (1985). Skin disease and handicap: An analysis of the impact of skin conditions. Society Science Medicine, 20, 425–429.
Kent, G. (1999). Correlates of perceived stigma in vitiligo. Psychology & Health, 14, 241–251.
Kent, G., & Al-Abadie, M. (1996). Factors affecting responses on dermatology life quality index items among vitiligo sufferers. Clinical Experimental Dermatology, 21, 330–333.
Kim, J. O., & Meuller, C. W. (1978). Factor analysis: Statistical methods and practical issues. London: Sage Publications Inc.
Kline, P. (1994). An easy guide to factor analysis. London: Routledge.
Lob-Corzilius, T., Boer, S., Scheewe, S., Wilke, K., Schon, M., Schule im Walde, J., et al. (2004). The ‘Skin Detective Questionnaire’: A survey tool for self-assessment of patients with atopic dermatitis. First results of its application. Dermatologica Psychosomatica, 5, 141–146.
Lu, Y., Duller, P., van der Valk, P. G. M., & Evers, A. W. M. (2003). Helplessness as predictor of perceived stigmatization in patient with psoriasis and atopic dermatitis. Dermatologica Psychosomatica, 4, 146–150.
Marsh, H. W. (1996). Positive and negative global self-esteem: A substantively meaningful distinction or artifactors? Journal of Social Psychology, 70, 810–819.
Perrott, S. B., Murray, A. H., Lowe, J., & Mathieson, C. M. (2000). The psychosocial impact of psoriasis: Physical severity, quality of life, and stigmatization. Physiology Behaviour, 70, 567–571.
Pett, M. A., Lackey, N. R., & Sullivan, J. J. (2003). Making sense of factor analysis: The use of factor analysis for instrument development in health care research. Thousand Oaks: Sage Publications Inc.
Richards, H. L., Fortune, D. G., Griffiths, C. E., & Main, C. J. (2001). The contribution of perceptions of stigmatization to disability in patients with psoriasis. Journal of Psychosomatic Research, 50, 11–15.
Richards, H. L., Fortune, D. G., Chong, S., Mason, D. L., Sweeney, S., Main, C. J., et al. (2004). Divergent beliefs about psoriasis are associated with increased psychological distress. Journal of Investigative Dermatology, 123, 122–130.
Richards, H. L., Fortune, D. G., Griffiths, C. E. M., & Main, C. J. (2005). Alexithymia in patients with psoriasis: Clinical correlates and psychometric properties of the Toronto Alexithymia Scale-20. Journal of Psychosomatic Research, 58, 89–96.
Scambler, G., & Hopkins, A. (1986). Being epileptic: Coming to terms with stigma. Sociology Health Illness, 8, 26–43. .
Schmid-Ott, G., Jäger, B., Ott, R., & Lamprecht, F. (1996). Dimensions of stigmatization in patients with psoriasis in a questionnaire on experience with skin complaints. Dermatology, 193, 304–310.
Schmid-Ott, G., Jäger, B., Künsebeck, H. W., Ott, R., Wedderer, K., & Lamprecht, F. (1998). Psychosocial influences on the illness experience of psoriasis patients. A study with the “Questionnaire on Experience with Skin Complaints [QES]”. Zeitschrift fürKlinische Psychologie,Psychiatrie und Psychotherapie, 46, 330–343.
Schmid-Ott, G., Künsebeck, H. W., Jäger, B., Werfel, T., Frahm, K., Ruitman, J., et al. (1999). Validity study for the stigmatization experience in atopic dermatitis and psoriatic patients. Acta Dermatological Venereologica, 79, 1–5.
Schmid-Ott, G., Burchard, R., Niederauer, H. H., Lamprecht, F., & Künsebeck, H. W. (2003). Stigmatization and quality of life of patients with psoriasis and atopic dermatitis. Hautarzt, 54, 852–857.
de Turner, S., & Cox, H. (2004). Facilitating post traumatic growth. Health Quality Life Outcomes, 2, 34. http://www.hqlo.com/content/2/1/34.
Vardy, D., Besser, A., Amir, M., Gesthalter, B., Biton, A., & Buskila, D. (2002). Experiences of stigmatization play a role in mediating the impact of disease severity on quality of life in psoriasis patients. British Journal of Dermatology, 147, 736–742.
Wittkowski, A. (2000). Research into the impact of eczema on the quality of life. Exchange, 98, 22–23.
Wittkowski, A. (2001). An investigation into predictors of quality of life in adults with atopic dermatitis. Unpublished Clin. Psy. D. thesis. University of Manchester, UK.
Wittkowski, A., & Richards, H. L. (2007). How beneficial is cognitive behaviour therapy in the treatment of atopic dermatitis: Reports from two single case designs. Psychology Health & Medicine, 12, 445–449.
Wittkowski, A., Richards, H. L., Griffiths, C. E. M., & Main, C. J. (2004). The impact of psychological and clinical factors on quality of life in individuals with atopic dermatitis. Journal of Psychosomatic Research, 57, 195–200.
Author information
Authors and Affiliations
Corresponding author
Appendix
Appendix
Rights and permissions
About this article
Cite this article
Wittkowski, A., Richards, H.L., Williams, J. et al. An Examination of the Psychometric Properties and Factor Structure of the Feelings of Stigmatization Questionnaire. J Clin Psychol Med Settings 14, 248–257 (2007). https://doi.org/10.1007/s10880-007-9074-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10880-007-9074-7